4//SEC Filing
Duker Jay S. 4
Accession 0001562180-25-000226
CIK 0001314102other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:03 PM ET
Size
20.1 KB
Accession
0001562180-25-000226
Insider Transaction Report
Form 4
Duker Jay S.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-01-05+30,000→ 68,027 total - Tax Payment
Common Stock
2025-01-05$8.26/sh−10,007$82,658→ 58,020 total - Exercise/Conversion
Common Stock
2025-01-06+20,794→ 78,814 total - Tax Payment
Common Stock
2025-01-06$8.68/sh−6,108$53,017→ 72,706 total - Award
Restricted Stock Units
2025-01-03+195,000→ 228,334 totalExercise: $0.00→ Common Stock (195,000 underlying) - Award
Stock Option (Right to Buy)
2025-01-03+390,000→ 390,000 totalExercise: $8.26Exp: 2035-01-03→ Common Stock (390,000 underlying) - Exercise/Conversion
Restricted Stock Units
2025-01-05−30,000→ 60,000 totalExercise: $0.00→ Common Stock (30,000 underlying) - Exercise/Conversion
Restricted Stock Units
2025-01-06−20,794→ 39,206 totalExercise: $0.00→ Common Stock (20,794 underlying)
Holdings
- 22,500(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
- [F2]These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]The restricted stock units will vest in three ratable annual installments beginning January 3, 2026.
- [F4]The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.
- [F5]The restricted stock units vests in three ratable annual installments beginning January 5, 2025.
- [F6]The restricted stock units vests in three ratable annual installments beginning January 6, 2024.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001630864
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:03 PM ET
- Size
- 20.1 KB